India Dr Reddy's gets FDA nod for trandolapril tabs
MUMBAI, Aug 29 (Reuters) - Indian drugmaker Dr Reddy's Laboratories Ltd (REDY.BO: Quote, Profile, Research, Stock Buzz) (RDY.N: Quote, Profile, Research, Stock Buzz) has received approval from the U.S. Food and Drug Administration for trandolapril tablets, the regulator's website showed.
The drug is a generic version of Abbott Laboratories' (ABT.N: Quote, Profile, Research, Stock Buzz) Mavik tablets, indicated in the treatment of hypertension. (Reporting by Rina Chandran; Editing by Ranjit Gangadharan)
© Thomson Reuters 2008 All rights reserved
Bracing for a brutal year
The media industry, fresh off a bruising 2008, is preparing for an even more brutal 2009 as the slump in advertising, fall in consumer spending and financial crisis show no signs of easing. Full Coverage
Defiant Cafe Leopold reopens
